- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01363167
Identifying Vitamin D Deficiency in Very Low Birth Weight Infant (VLBW) Infants Part 2
November 21, 2014 updated by: Sarah N Taylor, Medical University of South Carolina
Identifying Vit D Deficiency in VLBW Infants Part 2
This study is to determine the amount of vitamin D required for a very low birth weight infant to reach vitamin D sufficiency and achieve optimal calcium health and bone growth.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
68
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina
-
Charleston, South Carolina, United States, 29425-8750
- Medical University of South Carolina
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 3 days (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Any infant born at the Medical University of South Carolina <34 weeks gestation
- Less that 1500g at birth
- AGA
- Must be African American or Caucasian
- Each infant born of twin and triplet pregnancies will be eligible
Exclusion Criteria:
- Infants with major congenital anomalies or with hemolytic disease requiring exchange transfusion
- Infants born small for-gestational-age (SGA) or large for-gestational-age (LGA)
- Maternal uncontrolled thyroid disease
- Maternal Parathyroid disease
- Infants of races other than African American or Caucasian
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 400 IU Cholecalciferol - Vitamin D
|
Infants who are defined as vitamin D deficient at birth will be randomized to receive either 400 IU vitamin D/day or placebo daily until term age is reached.
|
Placebo Comparator: Placebo
Placebo contains Fractionated Coconut Oil
|
Infants who are defined as vitamin D deficient at birth will be randomized to receive either 400 IU vitamin D/day or placebo daily until term age is reached.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intestinal Calcium Absorption
Time Frame: When receiving at least 50% of nutrition enterally expected to occur at 2-6 weeks post-birth
|
When receiving at least 50% of nutrition enterally expected to occur at 2-6 weeks post-birth
|
|
Parathyroid hormone concentration
Time Frame: At term age (expected 2-4 months)
|
At term age (expected 2-4 months)
|
|
Serum 25 hydroxyvitamin D status
Time Frame: At term age (expected 2-4 months)
|
At term age (expected 2-4 months)
|
|
Bone Health
Time Frame: At term age (expected 2-4 months)
|
Bone ultrasound measurement, serum alkaline phosphatase, and bone-specific alkaline phosphatase at birth and monthly until term age.
Bone mineralization by DEXA scan at hospital discharge and term age.
|
At term age (expected 2-4 months)
|
Serum inflammatory cytokine concentrations
Time Frame: At birth (day 1)
|
At birth (day 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Phosphorus Homeostasis
Time Frame: At term age (expected 2-4 months)
|
Measurement of serum and urine phosphorus concentrations
|
At term age (expected 2-4 months)
|
Growth parameters
Time Frame: At term age (expected 2-4 months)
|
At term age (expected 2-4 months)
|
|
Vitamin D Dose Safety as Measured by Urinary Calcium Excretion
Time Frame: At term age (expected 2-4 months)
|
At term age (expected 2-4 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Sarah N. Taylor, M.D., Medical University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2011
Primary Completion (Actual)
October 1, 2013
Study Completion (Actual)
October 1, 2013
Study Registration Dates
First Submitted
April 18, 2011
First Submitted That Met QC Criteria
May 31, 2011
First Posted (Estimate)
June 1, 2011
Study Record Updates
Last Update Posted (Estimate)
November 24, 2014
Last Update Submitted That Met QC Criteria
November 21, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HR# 17217
- K23RR021891 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vitamin D Deficiency
-
University Hospital, Clermont-FerrandTerminated
-
Federal University of Rio Grande do SulCompletedDeficiency, Vitamin DBrazil
-
Rajavithi HospitalQueen Sirikit National Institute of Child HealthCompleted
-
Universidade de Passo FundoUnknownDeficiency, Vitamin DBrazil
-
Nutrition Institute, SloveniaEuropean Regional Development Fund; Vizera d.o.o.; Frutarom Etol d.o.o.CompletedVitamin B 12 Deficiency | Vitamin d Deficiency | Protein DeficiencySlovenia
-
Wageningen UniversityDSM Nutritional Products, Inc.; Top Institute Food and NutritionCompletedElderly, Frail | Deficiency, Vitamin DNetherlands
-
University of PaviaIstituti Clinici Scientifici Maugeri SpAUnknownVitamin D Deficiency | Vitamin D3 Deficiency | Vitamin DItaly
-
Okan UniversityArçelik A.Ş.Completed
-
Brigham and Women's HospitalCompletedVitamin d Deficiency
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingVitamin d DeficiencyChina
Clinical Trials on 400 IU Cholecalciferol- Vitamin D Daily
-
Augusta UniversityCompletedObesity | Overweight | Vitamin D DeficiencyUnited States
-
Medical University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
The Hospital for Sick ChildrenUnity Health Toronto; Mount Sinai Hospital, CanadaCompletedRespiratory Tract Infections | Avitaminosis | AsthmaCanada
-
Johns Hopkins UniversityNational Institute on Aging (NIA)TerminatedVitamin D Deficiency | FallsUnited States
-
University of MichiganCrohn's and Colitis FoundationTerminatedVitamin D Deficiency | Crohn's DiseaseUnited States
-
Mexican National Institute of Public HealthUnknown
-
National Institute of Allergy and Infectious Diseases...Autoimmunity Centers of ExcellenceTerminatedSystemic Lupus ErythematosusUnited States
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Fundación Cardiovascular de ColombiaUniversidad Industrial de Santander; Farma de Colombia SACompletedVitamin D Deficiency | Overweight and Obesity | Overweight AdolescentsColombia
-
Boston UniversityCompletedVitamin D DeficiencyUnited States